Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Biochem Funct ; 26(2): 279-82, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-17708577

RESUMO

We investigated possible involvement of three isozymes of prostaglandin E synthase (PGES), microsomal PGES-1 (mPGES-1), mPGES-2 and cytosolic PGES (cPGES) in COX-2-dependent prostaglandin E(2) (PGE(2)) formation following proteinase-activated receptor-2 (PAR2) stimulation in human lung epithelial cells. PAR2 stimulation up-regulated mPGES-1 as well as COX-2, but not mPGES-2 or cPGES, leading to PGE(2) formation. The PAR2-triggered up-regulation of mPGES-1 was suppressed by inhibitors of COX-1, cytosolic phospholipase A(2) (cPLA(2)) and MEK, but not COX-2. Finally, a selective inhibitor of mPGES-1 strongly suppressed the PAR2-evoked PGE(2) formation. PAR2 thus appears to trigger specific up-regulation of mPGES-1 that is dependent on prostanoids formed via the MEK/ERK/cPLA(2)/COX-1 pathway, being critical for PGE(2) formation.


Assuntos
Ciclo-Oxigenase 1/metabolismo , Dinoprostona/biossíntese , Células Epiteliais/enzimologia , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Oxirredutases Intramoleculares/metabolismo , Fosfolipases A2 Citosólicas/metabolismo , Receptor PAR-2/metabolismo , Ácidos Araquidônicos/farmacologia , Butadienos/farmacologia , Células Cultivadas , Ciclo-Oxigenase 1/efeitos dos fármacos , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , MAP Quinases Reguladas por Sinal Extracelular/efeitos dos fármacos , Perfilação da Expressão Gênica , Humanos , Indóis/farmacologia , Oxirredutases Intramoleculares/efeitos dos fármacos , Oxirredutases Intramoleculares/genética , Isoenzimas/efeitos dos fármacos , Isoenzimas/metabolismo , Pulmão/citologia , Nitrilas/farmacologia , Nitrobenzenos/farmacologia , Fosfolipases A2 Citosólicas/efeitos dos fármacos , Prostaglandina-E Sintases , Pirazóis/farmacologia , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/genética , Receptor PAR-2/efeitos dos fármacos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transdução de Sinais/efeitos dos fármacos , Sulfonamidas/farmacologia , Regulação para Cima/efeitos dos fármacos
2.
Regul Pept ; 145(1-3): 42-8, 2008 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-17854923

RESUMO

Proteinase-activated receptor-2 (PAR2) plays a dual role in the respiratory system, being pro- and anti-inflammatory. In human lung epithelial cells (A549), PAR2 activation causes release of interleukin-8 (IL-8) in addition to prostaglandin E(2) (PGE(2)). In the present study, we thus investigated PAR2-triggered signal transduction pathways causing IL-8 formation in A549 cells. SLIGRL-NH(2), a PAR2-activating peptide, but not LSIGRL-NH(2), a scrambled peptide, elicited release of IL-8 from A549 cells for 18 h, as measured by the ELISA method, an effect being suppressed by inhibitors of MEK, JNK, EGF receptor-tyrosine kinase (EGFR-TK), Src, pan-tyrosine kinases and protein kinase C, but not p38 MAP kinase or cyclooxygenase. SLIGRL-NH(2) also up-regulated IL-8 at protein and mRNA levels, as determined by Western blotting and RT-PCR, respectively. The PAR2-triggered up-regulation of IL-8 protein and mRNA was blocked by an inhibitor of MEK, but not clearly by inhibitors of JNK and EGFR-TK. SLIGRL-NH(2) actually phosphorylated JNK as well as ERK, the JNK activation being resistant to inhibitors of Src, pan-tyrosine kinases, protein kinase C and EGFR-TK. Our data suggest that PAR2-triggered IL-8 formation involves transcriptional up-regulation of IL-8 via the MEK-ERK pathway, while the JNK and EGF receptor pathways might rather contribute to a post-transcriptional process for the release of IL-8.


Assuntos
Células Epiteliais/metabolismo , Interleucina-8/biossíntese , Interleucina-8/metabolismo , Pulmão/metabolismo , Peptídeos/farmacologia , Receptor PAR-2/metabolismo , Transdução de Sinais/efeitos dos fármacos , Linhagem Celular Tumoral , Dinoprostona/metabolismo , Células Epiteliais/efeitos dos fármacos , Humanos , Interleucina-8/genética , Pulmão/efeitos dos fármacos , Receptor PAR-1/agonistas , Receptor PAR-1/metabolismo , Receptor PAR-2/agonistas , Regulação para Cima/efeitos dos fármacos , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
3.
Biochem Pharmacol ; 73(1): 103-14, 2007 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-17069767

RESUMO

Proteinase-activated receptor-1 (PAR1), a thrombin receptor, plays a protective role in gastric mucosa via prostanoid formation. Thus, we studied effects of PAR1 stimulation on prostaglandin E(2) (PGE(2)) formation in rat normal gastric mucosal epithelial RGM1 cells and analyzed the underlying signal transduction mechanisms. The PAR1-activating peptide (PAR1-AP) and thrombin increased PGE(2) release from RGM1 cells for 18h, an effect being suppressed by inhibitors of COX-1, COX-2, MEK, p38 MAP kinase (p38 MAPK), protein kinase C (PKC), Src and EGF receptor-tyrosine kinase (EGFR-TK), but not JNK and matrix metalloproteinase (MMP)/a disintegrin and metalloproteinases (ADAMs). PAR1-AP caused persistent (6h or more) and transient (5min) phosphorylation of ERK and p38 MAPK, respectively, followed by delayed reinforcement at 18h. PAR1-AP up-regulated COX-2 in a manner dependent on MEK and EGFR-TK, but not p38 MAPK. The PAR1-mediated persistent ERK phosphorylation was reduced by inhibitors of Src and EGFR-TK. PAR1-AP actually phosphorylated EGF receptors and up-regulated mRNA for heparin-binding-EGF (HB-EGF), the latter effect being blocked by inhibitors of Src, EGFR-TK and MEK. Heparin, an inhibitor for HB-EGF, suppressed PAR1-mediated PGE(2) formation and persistent ERK phosphorylation. These results suggest that PAR1 up-regulates COX-2 via persistent activation of MEK/ERK that is dependent on EGFR-TK activation following induction of HB-EGF, leading to PGE(2) formation. In addition, our data also indicate involvement of COX-1, PKC and p38 MAPK in PAR1-triggered PGE(2) formation. PAR1, thus stimulates complex multiple signaling pathways responsible for PGE(2) formation in RGM1 cells.


Assuntos
Dinoprostona/biossíntese , Mucosa Gástrica/metabolismo , Receptor PAR-1/metabolismo , Animais , Sequência de Bases , Ciclo-Oxigenase 2/metabolismo , Inibidores de Ciclo-Oxigenase/farmacologia , Primers do DNA , Fator de Crescimento Epidérmico/metabolismo , Células Epiteliais/metabolismo , Receptores ErbB/metabolismo , Mucosa Gástrica/citologia , Fator de Crescimento Semelhante a EGF de Ligação à Heparina , Peptídeos e Proteínas de Sinalização Intercelular , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Fosforilação , Ratos , Reação em Cadeia da Polimerase Via Transcriptase Reversa
4.
J Pharmacol Exp Ther ; 315(2): 576-89, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16120814

RESUMO

We investigated proteinase-activated receptor-2 (PAR(2))-triggered signal transduction pathways causing increased prostaglandin E(2) (PGE(2)) formation in human lung-derived A549 epithelial cells. The PAR(2) agonist, SLIGRL-NH(2) (Ser-Leu-Ile-Gly-Arg-Leu-amide), evoked immediate cytosolic Ca(2+) mobilization and delayed (0.5-3 h) PGE(2) formation. The PAR(2)-triggered PGE(2) formation was attenuated by inhibition of the following signal pathway enzymes: cyclooxygenases 1 and 2 (COX-1 and COX-2, respectively), cytosolic Ca(2+)-dependent phospholipase A(2) (cPLA(2)), the mitogen-activated protein kinases (MAPKs), mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) and p38 MAPK, Src family tyrosine kinase, epidermal growth factor (EGF) receptor tyrosine kinase (EGFRK), and protein kinase C (PKC), but not by inhibition of matrix metalloproteinases. SLIGRL-NH(2) caused prompt (5 min) and transient ERK phosphorylation, blocked in part by inhibitors of PKC and tyrosine kinases but not by an EGFRK inhibitor. SLIGRL-NH(2) also evoked a relatively delayed (15 min) and persistent (30 min) phosphorylation of p38 MAPK, blocked by inhibitors of Src and EGFRK but not by inhibitors of COX-1 or COX-2. SLIGRL-NH(2) elicited a Src inhibitor-blocked prompt (5 min) and transient phosphorylation of the EGFRK. SLIGRL-NH(2) up-regulated COX-2 protein and/or mRNA levels that were blocked by inhibition of p38 MAPK, EGFRK, Src, and COX-2 but not MEK-ERK. SLIGRL-NH(2) also caused COX-1-dependent up-regulation of microsomal PGE synthase-1 (mPGES-1). We conclude that PAR(2)-triggered PGE(2) formation in A549 cells involves a coordinated up-regulation of COX-2 and mPGES-1 involving cPLA(2), increased cytosolic Ca(2+), PKC, Src, MEK-ERK, p38 MAPK, Src-mediated EGF receptor trans-activation, and also metabolic products of both COX-1 and COX-2.


Assuntos
Dinoprostona/biossíntese , Células Epiteliais/metabolismo , Pulmão/metabolismo , Receptor PAR-2/fisiologia , Transdução de Sinais/efeitos dos fármacos , Western Blotting , Cálcio/metabolismo , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Ciclo-Oxigenase 1/biossíntese , Ciclo-Oxigenase 2/biossíntese , Citosol/efeitos dos fármacos , Citosol/metabolismo , Células Epiteliais/efeitos dos fármacos , Receptores ErbB/metabolismo , Humanos , Imuno-Histoquímica , Pulmão/citologia , Pulmão/efeitos dos fármacos , Microssomos/efeitos dos fármacos , Microssomos/enzimologia , Fosforilação , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Receptor PAR-1/agonistas , Receptor PAR-2/agonistas , Receptores de Estrogênio/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...